RAMP® NT-proBNP Test

The RAMP^® NT-proBNP test is an accurate, quantitative and rapid diagnostic test that aids in the diagnosis and assessment of severity in individuals suspected of having congestive heart failure (CHF) and can aid in the risk stratification of patients with heart failure. The RAMP^® NT-proBNP test is ideally suited for point of care testing and laboratory use by healthcare professionals.

Request Info Request Quote

Categories: Cardiac Testing, Cardiac Testing Analyzers Tags: NT-ProBNP, Cardiac Testing, Congestive Heart Failure (CHF)

Description

Product Description

The RAMP^® NT-proBNP test is an FDA cleared whole blood immunoassay BNP test, with proprietary RAMP technology, which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure. This product will help physicians and patients where a traditional BNP test cannot.

MANAGING PATIENTS WITH HEART FAILURE

1 out of 4 patients will be readmitted within 30 days of discharge, the highest rate of readmission of any discharge diagnosis
1 in 5 patients diagnosed with heart failure die within the first year and about half of people who develop heart failure die within 5 years of diagnosis
Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD
Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat.

RAMP NT-proBNP TEST

Provides rapid, accurate diagnoses and assessment of congestive heart failure.
NT-proBNP is roughly 5 times more stable of a biomarker then BNP
Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
Standardized to Roche Elecsys Lab Analyzer

RAMP NT-proBNP PUBLICATIONS

The RAMP^® 200 Reader

Features & Benefits

Rapid, accurate, lab quality results within minutes
Full range NT-proBNP measurement
Broad reportable range enables continuous clinical assessment following initial diagnosis
24 Hour Technical Support available